Plasma homocysteine levels and associated factors in community-dwelling adolescents: the EVA-TYROL study.

adolescents cardiovascular risk factors epidemiology health prevention homocysteine

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 31 01 2023
accepted: 01 06 2023
medline: 10 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

Homocysteine (Hcy) has been associated with an adverse cardiovascular risk profile in adolescents. Assessment of the association between plasma Hcy levels and clinical/laboratory factors might improve our understanding of the pathogenesis of cardiovascular disease. Hcy was measured in 1,900 14- to 19-year-old participants of prospective population-based EVA-TYROL Study (44.3% males, mean age 16.4 years) between 2015 and 2018. Factors associated with Hcy were assessed by physical examination, standardized interviews, and fasting blood analysis. Mean plasma Hcy was 11.3 ± 4.5 µmol/L. Distribution of Hcy was characterized by extreme right skew. Males exhibited higher Hcy and sex differences increased with increasing age. Univariate associations with Hcy emerged for age, sex, body mass index, high-density lipoprotein cholesterol, and for factors pertaining to blood pressure, glucose metabolism, renal function, and diet quality, whereas the most important multivariate predictors of Hcy were sex and creatinine. Clinical and laboratory factors associated with Hcy in adolescents were manifold, with sex and high creatinine identified as strongest independent determinants. These results may aid when interpreting future studies investigating the vascular risk of homocysteine.

Sections du résumé

Background UNASSIGNED
Homocysteine (Hcy) has been associated with an adverse cardiovascular risk profile in adolescents. Assessment of the association between plasma Hcy levels and clinical/laboratory factors might improve our understanding of the pathogenesis of cardiovascular disease.
Methods UNASSIGNED
Hcy was measured in 1,900 14- to 19-year-old participants of prospective population-based EVA-TYROL Study (44.3% males, mean age 16.4 years) between 2015 and 2018. Factors associated with Hcy were assessed by physical examination, standardized interviews, and fasting blood analysis.
Results UNASSIGNED
Mean plasma Hcy was 11.3 ± 4.5 µmol/L. Distribution of Hcy was characterized by extreme right skew. Males exhibited higher Hcy and sex differences increased with increasing age. Univariate associations with Hcy emerged for age, sex, body mass index, high-density lipoprotein cholesterol, and for factors pertaining to blood pressure, glucose metabolism, renal function, and diet quality, whereas the most important multivariate predictors of Hcy were sex and creatinine.
Discussion UNASSIGNED
Clinical and laboratory factors associated with Hcy in adolescents were manifold, with sex and high creatinine identified as strongest independent determinants. These results may aid when interpreting future studies investigating the vascular risk of homocysteine.

Identifiants

pubmed: 37424916
doi: 10.3389/fcvm.2023.1140990
pmc: PMC10327549
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1140990

Informations de copyright

© 2023 Gande, Hochmayr, Staudt, Bernar, Stock, Kiechl, Geiger, Griesmacher, Scholl-Bürgi, Knoflach, Pechlaner, Kiechl-Kohlendorfer and the (Early Vascular Ageing) EVA Study Group.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nutr Rev. 2021 Aug 9;79(9):1067-1078
pubmed: 33351941
BMC Cardiovasc Disord. 2020 Feb 5;20(1):59
pubmed: 32024473
J Pediatr. 2021 Jul;234:158-163.e2
pubmed: 33775664
Eur J Pediatr. 2006 May;165(5):326-31
pubmed: 16344991
N Engl J Med. 1998 Jun 4;338(23):1650-6
pubmed: 9614255
Nutr J. 2013 Nov 07;12(1):144
pubmed: 24195518
Am J Physiol Renal Physiol. 2007 Aug;293(2):F594-600
pubmed: 17537983
Stroke. 2009 Apr;40(4):1063-9
pubmed: 19211497
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356
Nutr Res. 2012 Nov;32(11):817-26
pubmed: 23176792
Circulation. 2016 Sep 20;134(12):e236-55
pubmed: 27515136
N Engl J Med. 1998 Apr 9;338(15):1042-50
pubmed: 9535670
Front Nutr. 2022 Mar 29;9:818836
pubmed: 35425802
Eur J Epidemiol. 2009;24(6):315-9
pubmed: 19396552
JAMA. 1999 Apr 7;281(13):1189-96
pubmed: 10199428
Pediatrics. 2009 Feb;123(2):627-35
pubmed: 19171631
Am J Clin Nutr. 2006 Jun;83(6):1380-6
pubmed: 16762950
Circulation. 2016 Jan 26;133(4):361-9
pubmed: 26673559
J Am Coll Cardiol. 2006 Mar 7;47(5):1005-11
pubmed: 16516085
Nutr Metab Cardiovasc Dis. 2012 Oct;22(10):900-6
pubmed: 21194911
Br J Nutr. 2017 Jan;117(1):124-133
pubmed: 28098048
J Nutr. 1996 Apr;126(4 Suppl):1281S-4S
pubmed: 8642471
J Nutr. 2003 Aug;133(8):2643-9
pubmed: 12888652
Metab Syndr Relat Disord. 2009 Aug;7(4):357-62
pubmed: 19558275
Nephrol Dial Transplant. 1999 Feb;14(2):366-8
pubmed: 10069190
Public Health Nutr. 2001 Apr;4(2B):493-7
pubmed: 11683544
Pediatrics. 2011 Apr;127(4):e978-88
pubmed: 21382947
Pediatr Res. 2006 Dec;60(6):764-9
pubmed: 17065574
JAMA. 1995 Nov 15;274(19):1526-33
pubmed: 7474221
Antioxid Redox Signal. 2011 Oct 1;15(7):1927-43
pubmed: 21126196
Cochrane Database Syst Rev. 2017 Aug 17;8:CD006612
pubmed: 28816346
Turk J Pediatr. 2013 Sep-Oct;55(5):510-8
pubmed: 24382532
Metabolism. 2006 Aug;55(8):1007-13
pubmed: 16839834
Circulation. 2000 Aug 22;102(8):852-7
pubmed: 10952952
Metabolism. 1998 Jun;47(6):686-9
pubmed: 9627367
Am J Epidemiol. 2002 Dec 15;156(12):1105-13
pubmed: 12480655
Diabetes Care. 2000 Sep;23(9):1348-52
pubmed: 10977031
J Nutr. 2004 Apr;134(4):913-8
pubmed: 15051846
Amino Acids. 2001;20(4):409-18
pubmed: 11452984
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
Eur J Clin Nutr. 2002 Jul;56(7):644-9
pubmed: 12080404
J Intern Med. 2021 Oct;290(4):826-854
pubmed: 33660358
Antioxid Redox Signal. 2007 Nov;9(11):1875-81
pubmed: 17854288
J Intern Med. 2000 Feb;247(2):287-94
pubmed: 10692093
Ann Epidemiol. 2004 Mar;14(3):229-33
pubmed: 15036228
Am J Pathol. 1969 Jul;56(1):111-28
pubmed: 5792556

Auteurs

Nina Gande (N)

Department of Pediatrics II (Neonatology), Medical University of Innsbruck, Innsbruck, Austria.

Christoph Hochmayr (C)

Department of Pediatrics II (Neonatology), Medical University of Innsbruck, Innsbruck, Austria.

Anna Staudt (A)

Department of Pediatrics II (Neonatology), Medical University of Innsbruck, Innsbruck, Austria.

Benoît Bernar (B)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Katharina Stock (K)

Department of Pediatrics III (Cardiology), Medical University of Innsbruck, Innsbruck, Austria.

Sophia J Kiechl (SJ)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Ralf Geiger (R)

Department of Pediatrics III (Cardiology), Medical University of Innsbruck, Innsbruck, Austria.
Department of Pediatrics, Bruneck Hospital, Bruneck, Italy.

Andrea Griesmacher (A)

Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Innsbruck, Austria.

Sabine Scholl-Bürgi (S)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Michael Knoflach (M)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Raimund Pechlaner (R)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Ursula Kiechl-Kohlendorfer (U)

Department of Pediatrics II (Neonatology), Medical University of Innsbruck, Innsbruck, Austria.

Classifications MeSH